NEW EMBO MEMBERS' REVIEW: Hsp70 interactions with the p53 tumour suppressor protein

Abstract

New EMBO Member's Review3 September 2001free access Hsp70 interactions with the p53 tumour suppressor protein Maciej Zylicz Corresponding Author Maciej Zylicz Department of Molecular Biology, International Institute of Molecular and Cell Biology UNESCO, Warsaw, 02-109 Poland Search for more papers by this author Frank W King Frank W King Institute of Biochemistry and Biophysics PAS, Warsaw, 02-109 Poland Search for more papers by this author Alicja Wawrzynow Alicja Wawrzynow Department of Molecular Biology, International Institute of Molecular and Cell Biology UNESCO, Warsaw, 02-109 Poland Search for more papers by this author Maciej Zylicz Corresponding Author Maciej Zylicz Department of Molecular Biology, International Institute of Molecular and Cell Biology UNESCO, Warsaw, 02-109 Poland Search for more papers by this author Frank W King Frank W King Institute of Biochemistry and Biophysics PAS, Warsaw, 02-109 Poland Search for more papers by this author Alicja Wawrzynow Alicja Wawrzynow Department of Molecular Biology, International Institute of Molecular and Cell Biology UNESCO, Warsaw, 02-109 Poland Search for more papers by this author Author Information Maciej Zylicz 1, Frank W King2 and Alicja Wawrzynow1 1Department of Molecular Biology, International Institute of Molecular and Cell Biology UNESCO, Warsaw, 02-109 Poland 2Institute of Biochemistry and Biophysics PAS, Warsaw, 02-109 Poland *Corresponding author. E-mail: [email protected] The EMBO Journal (2001)20:4634-4638https://doi.org/10.1093/emboj/20.17.4634 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Introduction The heat shock proteins (HSPs) are encoded by genes whose expression is substantially increased during stress conditions, such as heat shock, alcohol, inhibitors of energy metabolism, heavy metals, oxidative stress, fever or inflammation. During these conditions, HSPs increase cell survival by protecting and disaggregating stress-labile proteins (Skowyra et al., 1990), as well as the proteolysis of the damaged proteins (Wickner et al., 1999). Under non-stress conditions, HSPs have multiple housekeeping functions, such as folding and translocating newly synthesized proteins, activation of specific regulatory proteins, including transcription factors, replication proteins and kinases, protein degradation, protein signalling, including steroid hormone activation and tumour immunogenicity, and antigen presentation (for reviews see Helmbrecht et al., 2000; Jolly and Morimoto, 2000). This broad spectrum of functions gave rise to the term ‘molecular chaperone’, an entity that acts to assist other proteins folding and maturating in the cell. It should also be emphasized that not all HSPs are molecular chaperones and not all chaperones are HSPs (Ellis and Hartl, 1999). HSPs are designated nomenclature according to their approximate molecular weight, e.g. the 70 kDa HSP is known as the molecular chaperone Hsp70. The 70 kDa heat shock-related proteins comprise a family of highly conserved molecular chaperones that regulate a wide variety of cellular processes during normal and stress conditions (Boorstein et al., 1994). Hsp70 is one of the most abundant of these proteins, accounting for as much as 1–2% of total cellular protein (Herendeen et al., 1979). In humans, there are at least 11 distinct genes that code for Hsp70 isoforms, which are located on several different chromosomes (Tavaria et al., 1996). The major, constitutively expressed hsp70 isoform is called hsc70 (gene product known as the clathrin-uncoating ATPase or Hsp73) (Welch, 1992). The transcription of inducible forms of hsp70 or hsp72 are under the control of the heat shock factor (HSF) (Morimoto, 1998), as well as a variety of physiological processes, such as cell cycle control, proliferation and differentiation (Helmbrecht et al., 2000; Jolly and Morimoto, 2000). The ATPase activity and peptide binding properties (Zylicz et al., 1983) have been conserved amongst both the eukaryotic and prokaryotic Hsp70 homologues (McKay et al., 1994). Hsp70 co-chaperones, such as Hsp40 (Liberek et al., 1991a; Kelley, 1998), Bag-1 (Hohfeld and Jentsch, 1997; Luders et al., 2000; Sondermann et al., 2001), Hip (Hohfeld et al., 1995) and Hop (Dittmar et al., 1996; Chen et al., 1998) have been shown to play an important role in modulating Hsp70 activity, as well as protein substrate specificity. In the absence of Hsp40 and ATP, Hsp70 preferentially binds to peptides (Fourie et al., 1994) and denatured protein (Liberek et al., 1991b). However, Hsp70 can also recognize and specifically bind to mature, folded proteins (for reviews see Wawrzynow and Zylicz, 1995; Mayer et al., 2000). In the presence of Hsp40, Hsp70 exhibits a broader range of substrate specificity (Wawrzynow et al., 1995; Misselwitz et al., 1998). The existence of several different isoforms of both Hsp70 and Hsp40 could result in the formation of multiple types of Hsp70–Hsp40 complexes that differ in substrate specificity (Zhen and Cyr, 1998). Hsp70 and other chaperones are also known to be determinants of cell death and cell transformation processes. The elevated expression of Hsp70 and Hsp90 in tumour cells was detected in several cases (for reviews see Helmbrecht et al., 2000; Jolly and Morimoto, 2000). In breast cancer, the expression of Hsp70 was correlated with metastasis and poor prognosis (Ciocca et al., 1993; Lin et al., 1994; Vargas-Roig, 1998). The overexpression of Hsp70 in several cell types increased transformation (Jaattela, 1995; Seo et al., 1996; Volloch and Sherman, 1999). Consistent with these observations, the inhibition of Hsp70 expression by anti-sense Hsp70 cDNA resulted in the inhibition of tumour cell proliferation and the induction of apoptosis (Wei et al., 1995; Jaattela et al., 1998). Hsp70 chaperone activity may influence tumorigenesis by regulating the activity of proteins that are involved in cell cycle machinery. Hsp70 family members and/or Hsp90 transiently associate with key molecules of the cell cycle control systems, including p53, Cdk4, Wee-1, c-Myc, pRb and p27/Kip1 (for reviews see Helmbrecht et al., 2000; Jolly and Morimoto, 2000). Hsp70 and/or Hsp90 also interact with important kinases of the mitogen-activated signal cascades, such as Src kinases, tyrosine receptor kinases, Raf and MAP-kinases (for reviews see Gabai et al., 2000; Helmbrecht et al., 2000; Song et al., 2001). Many recent, interesting observations have also been made with regards to Hsp70's ability to negatively regulate various stages of the p53-dependent or independent apoptotic pathways (Beere et al., 2000; Gabai et al., 2000; Li et al., 2000; Mosser et al., 2000; Nylandsted et al., 2000b). However, this review will focus only on the role of Hsp70 and its co-chaperones in the regulation of p53 function. Molecular chaperones are potential mediators of p53 conformation The p53 tumour suppressor protein functions as a transcriptional activator that binds specifically to double-stranded DNA. p53 is normally expressed at low levels in a latent form that is unable to bind specifically to DNA. Exposure to many stress signals, such as ionizing and non-ionizing radiation, hypoxia, anti-metabolites that inhibit ribonucleotide biosynthesis, heat shock, radiation and low extracellular pH, and DNA damage by chemicals, activates p53 protein and promotes cell cycle arrest. However, in response to certain oncogenic changes or when the stress is excessive, p53 can induce tumour-suppressive apoptotic cell death. This implies that there is strong selection for tumour cells to lose p53 function (for reviews see Hupp et al., 2000; Zhao et al., 2000; Evan and Vousden, 2001). The inactivation of wild-type p53 function can occur by proteolysis, chemical or protein modification, nuclear exclusion (cytoplasmic sequestration), or mutations in the p53 gene. The Mdm2 protein has been shown to inhibit p53 activity by binding to the p53 transactivation domain and interfering with the recruitment of basal transcription machinery components (for review see Hupp et al., 2000). In addition, Mdm2 can mediate p53 degradation by targeting its ubiquitylation. Wild-type p53 can stimulate the transcription of the mdm2 gene, which creates a negative feedback loop for p53 deactivation (for review see Hupp et al., 2000). Point mutations in the p53 gene are detected in >50% of the most common cancers (for reviews see Greenblatt et al., 1994; Lin et al., 1994). Mutated p53 protein exhibits a decreased ability to bind DNA and/or an altered protein conformation (Cho et al., 1994). Conformational mutants are also called class II or dominant-negative p53 mutants, and they display no wild-type conformation as detected by monoclonal antibodies (Gannon et al., 1990). Temperature-sensitive mutants, such as p53Ala135Val and p53Val143Ala, can revert back and forth between wild-type and mutant conformations in a temperature-dependent manner (Michalovitz et al., 1990; Zhang et al., 1994). The results from several in vivo experiments also suggest that wild-type p53 may exist in a constant state of equilibrium between wild-type and mutant conformations. In murine fibroblasts, which contained genetypically wild-type p53, a change from wild-type to mutant p53 conformation was observed on serum starvation (Milner and Watson, 1990). Wild-type p53 could also be converted to the mutant conformation in the presence of Cu(II) (Hainaut et al., 1995). In addition, mutant p53 conformation was shifted to wild-type conformation through interactions with p53 C-terminal peptides and the mutant p53 core domain (Selivanova et al., 1997, 1999). When one wild-type dimer of a tetramer p53 protein binds to a DNA half-site, the other non-bound dimer can possess wild-type or mutant conformation (McLure and Lee, 1999). Proteins that stabilize p53 DNA binding conformation may, indeed, stabilize wild-type p53 DNA complexes by facilitating a conformational shift towards wild-type conformation. Recently, we have demonstrated that Hsp90 can bind to wild-type p53 and stabilize wild-type p53–DNA complexes at 25°C, as well as partially protect wild-type p53 DNA binding conformation during long-term exposures at 37°C (F.W.King et al., in preparation). Chaperones such as Hsp90 may play a role in regulating the shift between wild-type and mutant p53 conformations (Figure 1). Figure 1.Hypothetical model for the involvement of molecular chaperones in the import and export of wild-type and mutant p53. Under non-stress conditions, there exists equilibrium between the import and export of wild-type p53 in and out of the nucleus. We propose that wild-type p53 may be escorted to the nucleus by chaperones, such as Hsp90. The binding of Hsp90 to wild-type p53 inhibits the formation of multiple chaperone complexes with wild-type p53. Bag-1 may dissociate the Hsp90–wtp53 complex facilitating the p53 degradation by proteosome or calpain-mediated pathways. During stress conditions, wild-type p53 is post-translationally modified (e.g. phosphorylation), which leads to the formation of active p53 tetramers. In the nucleus, activated wild-type p53 acts as a transcription factor, regulating the expression of genes involved in cell arrest, DNA repair and apoptosis. p53 also induces the transcription of other genes including hsp70. Mutant p53, which does not interact directly with Hsp90, can form a multichaperone complex in the cytoplasm, resulting in the increased stability and the cytoplasmic sequestration of mutant p53. We propose that during stress conditions, wild-type p53 located in the cytoplasm could temporarily adopt the mutant conformation, which initiates the formation of a multichaperone complex that could partially stabilize the wild-type p53 and prevent nuclear import by masking the p53 NLS. During recovery from stress exposure, Hsp90 and other proteins may be able to rescue such wild-type p53 protein that has acquired the mutant conformation. During recovery from stress, wild-type p53 tetramers located in the nucleus could be dissociated in the presence of Hsp70 and Hsp40, thus inhibiting p53 transcriptional activity. In addition, chaperones may participate in regulating the localization of wild-type p53 in some cancer cells. The Mot-2 protein, in the absence of an appropriate Hsp40 co-chaperone, may induce the aggregation of wild-type p53 in cytoplasm, which results in the inhibition of apoptosis in cancer cells. We propose that such an effect of Mot-2 could be reversed by the presence of Hsc70 and Hsp40 chaperones. Download figure Download PowerPoint Hsc70, Hsp90 and co-chaperones play a role in the stabilization and localization of mutant p53 Several different laboratories have identified either Hsc70 or Hsp70 in stable immunocomplexes with the conformational mutant form of p53 protein, but not wild-type p53 protein (for review see Hupp et al., 2000). In addition to Hsc/p70, Hsp90 and various co-chaperones have also been found to be associated with the p53 protein. In mammary tumour cell lines, both Hsc70 and Hsp90 were found associated with mutated p53 in the cytoplasm (Blagosklonny et al., 1996). Hsp40 has also been found associated with a mutant p53 immunocomplex (Sugito et al., 1995). Whitesell and co-workers utilized the temperature-sensitive murine p53 mutant p53Ala135Val, expressed in A1-5 fibroblasts, to demonstrate that chaperones Hsc70, Hsp90, p23 and cyclophilin 40 exclusively co-immunoprecipitate with the mutant form of p53 at 37°C. At lower temperatures favouring wild-type conformation (30°C), multiple chaperones complexes were not detected and p53 transcriptional activity was restored (Whitesell et al., 1998). A reconstituted in vitro system was recently used to demonstrate that the formation of a stable Bag-1-resistant complex between Hsp90 and mutant p53Arg175His requires the presence of Hsp40, Hsc70, Hop and ATP (F.W.King et al., in preparation). On the other hand, Hsp90 alone can bind directly to wild-type p53 and compete against both Hsc70 and Hsp40 for binding to wild-type p53 (F.W.King et al., in preparation). Cellular levels of wild-type p53 are ultimately regulated by either the proteasome degradation pathway (Maki et al., 1996) or the calcium-dependent protease calpain (Pariat et al., 1997). Hsp90-associated multiple chaperone complexes with mutant p53 protein have been linked to the impairment of mutant p53 ubiquitylation. Treatment of cells that express mutant p53 protein with the antibiotic geldanamycin results in an increase of mutant p53 ubiquitylation and proteosome-mediated degradation (Whitesell et al., 1997). In addition, geldanamycin was also shown to reduce the levels of Hsp90 bound to mutant p53 and increase mutant p53 translocation into the nucleus (Whitesell et al., 1998). Recent studies demonstrated that multiple chaperone complexes play an important role in masking the p53 nuclear localization signal (NLS) sequence while in a complex with the conformational mutant p53 (Akakura et al., 2001). Hsc70 in a complex with mutant p53 and other chaperones, such as Hsp90, prevented the NLS from accessing the nuclear import receptor, whereas nuclear import of p53 possessing wild-type conformation was not affected (Akakura et al., 2001). These combined results clearly demonstrate that multiple chaperone complexes with mutant p53 are the factors mediating the stabilization and cytoplasmic sequestration of conformational mutant p53 (Figure 1). Hsp70 family members participate in the cytoplasmic sequestration of wild-type p53 in cancer cells In addition to mutant p53 retention in the cytoplasm, events involving the accumulation of wild-type p53 have been discovered in various tumour cells. In the absence of stress, human tumour cells, including neuroblastoma, breast cancer, colon cancer, retinoblastoma, as well as normal embryonic stem cells, have displayed the accumulation of high levels of wild-type p53 protein in the cytoplasm (for review see Helmbrecht et al., 2000). In colon carcinomas, cytoplasmic accumulation of wild-type p53 correlates with poor prognosis (Bosari et al., 1995). Cytoplasmically sequestered wild-type p53 protein is resistant to Mdm2-mediated degradation (Zaika et al., 1999) and it displays a high degree of aggregation that impairs the G1 checkpoint following DNA damage (Moll et al., 1996). Three potential NLSs have been proposed to reside in the C-terminal domain of p53 and are required for p53 entry into the nucleus (Zerrahn et al., 1992). The truncated form of importin α, identified in breast cancer cells, is deficient in its ability to import wild-type p53 into the nucleus, resulting in the cytoplasmic sequestration of p53 (Kim et al., 2000). The mot-2 gene product, originally cloned from immortal murine cells, was shown to interact with sequestered wild-type p53 in the cytoplasm of immortal cells (Wadhwa et al., 1998). Interestingly, mot-2 is a member of the Hsp70 family that perform chaperone functions in the mitochondria (Wadhwa et al., 1998). The nuclear export signal (NES), located in the p53 tetramerization domain, is required for subcellular localization of p53 (Stommel et al., 1999). The leucine-rich NES sequence of p53 is masked upon nuclear p53 tetramerization, which inhibits the export of p53 from the nucleus and p53 degradation (Stommel et al., 1999). Cellular stress, such as ionizing radiation, has long been known to stabilize p53 and its nuclear accumulation (for review see Jimenez et al., 1999). Peptides derived from the p53 C-terminal tetramerization domain can mask the p53 NES sequence (but not the NLS), which facilitates nuclear localization of wild-type p53 in neuroblastoma cells (Stommel et al., 1999). These results together imply that proteins interacting with the p53 C-terminal domain may play a role in regulating the equilibrium of p53 translocation between the nuclear and cytoplasmic compartments. We propose that molecular chaperones could be involved in the regulation of p53 localization in either stressed or normal cellular conditions (Figure 1). Conclusions Cell survival during stress requires induction of the heat shock response. The expression of heat shock genes provides an adaptive mechanism for stress tolerance. However, the same adaptive mechanism can ultimately harm healthy cell growth by negatively influencing pathways that regulate cell growth control and apoptosis. It still remains unclear how HSPs, such as Hsp70, interfere with normal growth processes. These unknown effects of Hsp70 can be potentially problematic for new therapeutic applications, such as the regulation of Hsp70 expression as a tool to induce apoptosis in cancer cells (Nylandsted et al., 2000a), and the use of Hsp70 protein to create new types of adjuvants for vaccines that specifically target tumour cells or increase cell resistance to viral infections (Janetzki et al., 2000; Menoret et al., 2000; Srivastava and Jaikaria, 2001), which are part of a new era in molecular medicine. Acknowledgements This work was supported by the State Committee for Scientific Research Grant number 6P04A4219, Foundation for Polish Science, UNESCO grant. References Akakura S, Yoshida M, Yoneda Y and Horinouchi S (2001) A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135). J Biol Chem, 276, 14649–14657.CrossrefCASPubMedWeb of Science®Google Scholar Beere HM et al. (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nature Cell Biol, 2, 469–475.CrossrefCASPubMedWeb of Science®Google Scholar Blagosklonny MV, Toretsky J, Bohen S and Neckers L (1996) Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc Natl Acad Sci USA, 93, 8379–8383.CrossrefCASPubMedWeb of Science®Google Scholar Boorstein WR, Ziegelhoffer T and Craig EA (1994) Molecular evolution of the Hsp70 multigene family. J Mol Evol, 38, 1–17.CrossrefCASPubMedWeb of Science®Google Scholar Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, Lee AK and Coggi G (1995) p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol, 147, 790–798.CASPubMedWeb of Science®Google Scholar Chen S and Smith DF (1998) Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery. J Biol Chem, 273, 35194–35200.CrossrefCASPubMedWeb of Science®Google Scholar Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumor suppressor–DNA complex: understanding tumorigenic mutations. Science, 265, 346–355.CrossrefCASPubMedWeb of Science®Google Scholar Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ and McGuire WL (1993) Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst, 85, 570–574.CrossrefCASPubMedWeb of Science®Google Scholar Dittmar KD, Hutchison KA, Owens-Grillo JK and Pratt WB (1996) Reconstitution of the steroid receptor–hsp90 heterocomplex assembly system of rabbit reticulocyte lysate. J Biol Chem, 271, 12833–12839.CrossrefCASPubMedWeb of Science®Google Scholar Ellis RJ and Hartl FU (1999) Principles of protein folding in the cellular environment. Curr Opin Struct Biol, 9, 102–110.CrossrefCASPubMedGoogle Scholar Evan GI and Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342–347.CrossrefCASPubMedWeb of Science®Google Scholar Fourie AM, Sambrook JF and Gething MJ (1994) Common and divergent peptide binding specificities of hsp70 molecular chaperones. J Biol Chem, 269, 30470–30478.CrossrefCASPubMedWeb of Science®Google Scholar Gabai VL, Yaglom JA, Volloch V, Meriin AB, Force T, Koutroumanis M, Massie B, Mosser DD and Sherman MY (2000) Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol, 20, 6826–6836.CrossrefCASPubMedWeb of Science®Google Scholar Gannon JV, Greaves R, Iggo R and Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J, 9, 1595–1602.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855–4878.CASPubMedWeb of Science®Google Scholar Hainaut P, Rolley N, Davies M and Milner J (1995) Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene, 10, 27–32.CASPubMedWeb of Science®Google Scholar Helmbrecht K, Zeise E and Rensing L (2000) Chaperone in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif, 33, 341–365.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Herendeen SL, Van Bogelen RA and Neidhardt FC (1979) Levels of the major proteins of Escherichia coli during growth at different temperatures. J Bacteriol, 139, 185–194.CrossrefCASPubMedWeb of Science®Google Scholar Hohfeld J and Jentsch S (1997) GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J, 16, 6209–6216.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Hohfeld J, Minami Y and Hartl FU (1995) Hip, a novel cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle. Cell, 83, 589–598.CrossrefCASPubMedWeb of Science®Google Scholar Hupp TR, Lane DP and Ball KL (2000) Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochem J, 352, 1–17.CrossrefCASPubMedWeb of Science®Google Scholar Jaattela M (1995) Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer, 60, 689–693.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Jaattela M, Wissing D, Kokholm K, Kallunki T and Egeblad M (1998) Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J, 17, 6124–6134.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Janetzki S, Palla D, Rosenhauer V, Lochs H, Lewis JJ and Srivastava PK (2000) Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer, 88, 232–238.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Jimenez GS, Khan SH, Stommel JM and Wahl GM (1999) p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene, 18, 7656–7665.CrossrefCASPubMedWeb of Science®Google Scholar Jolly C and Morimoto RI (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst, 92, 1564–1572.CrossrefCASPubMedGoogle Scholar Kelley WL (1998) The J-domain family and the recruitment of chaperone power. Trends Biochem Sci, 23, 222–227.CrossrefCASPubMedWeb of Science®Google Scholar Kim IS et al. (2000) Truncated form of importin α identified in breast cancer cell inhibits nuclear import of p53. J Biol Chem, 275, 23139–23145.CrossrefCASPubMedWeb of Science®Google Scholar Li CY, Lee JS, Ko YG, Kim JI and Seo JS (2000) Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem, 275, 25665–25671.CrossrefCASPubMedWeb of Science®Google Scholar Liberek K, Marszalek J, Ang D, Georgopoulos C and Zylicz M (1991a) Escherichia coli DnaJ and GrpE heat shock proteins jointly stimulate ATPase activity of DnaK. Proc Natl Acad Sci USA, 88, 2874–2878.CrossrefCASPubMedWeb of Science®Google Scholar Liberek K, Skowyra D, Zylicz M, Johnson C and Georgopoulos C (1991b) The Escherichia coli DnaK chaperone, the 70-kDa heat shock protein eukaryotic equivalent, change conformation upon ATP hydrolysis, thus triggering its dissociation from a bound target protein. J Biol Chem, 266, 14491–14496.CrossrefCASPubMedWeb of Science®Google Scholar Lin J, Wu X, Chen J, Chang A and Levine AJ (1994) Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harb Symp Quant Biol, 59, 215–223.CrossrefCASPubMedWeb of Science®Google Scholar Luders J, Demand J and Hohfeld J (2000) The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem, 275, 4613–4617.CrossrefCASPubMedWeb of Science®Google Scholar Maki CG, Huibregtse JM and Howley PM (1996) In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res, 56, 2649–2654.CASPubMedWeb of Science®Google Scholar Mayer MP, Rudiger S and Bukau B (2000) Molecular basis for interactions of the DnaK chaperone with substrates. Biol Chem, 381, 877–885.CrossrefCASPubMedWeb of Science®Google Scholar McKay DB, Wilbanks SM, Flaherty KM, Ha JH, O'Brien MC, and Shirvanee LL (1994) Stress-70 proteins and their interaction with nucleotides. In Morimoto,R.I., Tissieres,A. and Georgopoulos,C. (eds), The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 153–177.Google Scholar McLure KG and Lee PW (1999) p53 DNA binding can be modulated by factors that alter the conformational equilibrium. EMBO J, 18, 763–770.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Menoret A, Chandawarkar RY and Srivastava PK (2000) Natural autoantibodies against heat-shock proteins hsp70 and gp96: implications for immunotherapy using heat-shock proteins. Immunology, 101, 364–370.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Michalovitz D, Halevy O and Oren M (1990) Conditional inhibition of transformation and cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671–680.CrossrefCASPubMedWeb of Science®Google Scholar Milner J and Watson JV (1990) Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein. Oncogene, 5, 1683–1690.CASPubMedWeb of Science®Google Scholar Misselwitz B, Staeck O and Rapoport TA (1998) J proteins catalytically activate Hsp70 molecules to trap a wide range of peptide sequences. Mol Cell, 2, 593–603.CrossrefCASPubMedWeb of Science®Google Scholar Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M and Zambetti G (1996) Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol, 16, 1126–1137.CrossrefCASPubMedWeb of Science®Google Scholar Morimoto RJ (1998) Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones and negative regulators. Genes Dev, 12, 3788–3796.CrossrefCASPubMedWeb of Science®Google Scholar Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI and Massie B (2000) The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol, 20, 7146–7159.CrossrefCASPubMedWeb of Science®Google Scholar Nylandsted J, Brand K and Jaattela M (2000a) Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci, 926, 122–125.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F and Jaattela M (2000b) Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA, 97, 7871–7876.CrossrefCASPubMedWeb of Science®Google Scholar Pariat M, Carillo S, Molinari M, Salvat C, Debussche L, Bracco L, Milner J and Piechaczyk M (1997) Proteolysis by calpains: a possible contribution to degradation of p53. Mol Cell Biol, 17, 2806–2815.CrossrefCASPubMedWeb of Science®Google Scholar Selivanova G, Iotsova V, Okan I, Fritsche M, Strom M, Groner B, Grafstrom RC and Wiman KG (1997) Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nature Med, 3, 632–638.CrossrefCASPubMedWeb of Science®Google Scholar Selivanova G, Ryabchenko L, Jansson E, Iotsova V and Wiman KG (1999) Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain. Mol Cell Biol, 19, 3395–3402.CrossrefCASPubMedWeb of Science®Google Scholar Seo JS, Park YM, Kim JI, Shim EH, Kim CW, Jang JJ, Kim SH and Lee WH (1996) T cell lymphoma in transgenic mice expressing the human Hsp70 gene. Biochem Biophys Res Commun, 218, 582–587.CrossrefCASPubMedWeb of Science®Google Scholar Skowyra D, Georgopoulos C and Zylicz M (1990) The Escherichia coli dnaK gene product, the hsp70 homologue, can reactivate heat-inactivated RNA polymerase in an ATP hydrolysis-dependent manner. Cell, 62, 939–944.CrossrefCASPubMedWeb of Science®Google Scholar Sondermann H, Scheufler C, Schneider C, Hohfeld J, Hartl FU and Moerefi I (2001) Structure of a Bag/Hsc70 complex: convergent functional evolution of Hsp70 nucleotide exchange factors. Science, 291, 1553–1557.CrossrefCASPubMedWeb of Science®Google Scholar Song J, Takeda M and Morimoto RI (2001) Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nature Cell Biol, 3, 276–282.CrossrefCASPubMedWeb of Science®Google Scholar Srivastava PK and Jaikaria NS (2001) Methods of purification of heat shock protein–peptide complexes for use as vaccines against cancers and infectious diseases. Methods Mol Biol, 156, 175–186.CASPubMedGoogle Scholar Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ and Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J, 18, 1660–1672.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Sugito K, Yamane M, Hattori H, Hayashi Y, Tohnai I, Ueda M, Tsuchida N and Ohtsuka K (1995) Interaction between hsp70 and hsp40, eukaryotic homologues of DnaK and DnaJ, in human cells expressing mutant-type p53. FEBS Lett, 358, 161–164.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Tavaria M, Gabriele T, Kola I and Anderson RL (1996) A hitchhikers guide to the human Hsp70 family. Cell Stress Chaperones, 1, 23–28.CrossrefCASPubMedWeb of Science®Google Scholar Vargas-Roig LM, Gago FE, Tello O, Aznar JC and Ciocca DR (1998) Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer, 79, 468–475.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Volloch VZ and Sherman MY (1999) Oncogenic potential of Hsp72. Oncogene, 18, 3648–3651.CrossrefCASPubMedWeb of Science®Google Scholar Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, Mitsui Y and Kaul SC (1998) Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem, 273, 29586–29591.CrossrefCASPubMedWeb of Science®Google Scholar Wawrzynow A and Zylicz M (1995) Divergent effects of ATP on the binding of the DnaK and DnaJ chaperones to each other, or to their various native and denatured protein substrates. J Biol Chem, 270, 19300–19306.CrossrefCASPubMedWeb of Science®Google Scholar Wawrzynow A, Banecki B, Wall D, Liberek K, Georgopoulos C and Zylicz M (1995) ATP hydrolysis is required for the DnaJ-dependent activation of DnaK chaperone for binding to both native and denatured protein substrates. J Biol Chem, 270, 19307–19311.CrossrefCASPubMedWeb of Science®Google Scholar Wei YQ, Zhao X, Kariya Y, Teshigawara K and Uchida A (1995) Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells. Cancer Immunol Immunother, 40, 73–78.CrossrefCASPubMedWeb of Science®Google Scholar Welch WJ (1992) Mammalian stress response: cell physiology, structure/function of stress proteins and implications for medicine and disease. Physiol Rev, 72, 1063–1081.CrossrefCASPubMedWeb of Science®Google Scholar Whitesell L, Sutphin P, An WG, Schulte T, Blagosklonny MV and Neckers L (1997) Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene, 14, 2809–2816.CrossrefCASPubMedWeb of Science®Google Scholar Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD and Cook PH (1998) The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol, 18, 1517–1524.CrossrefCASPubMedWeb of Science®Google Scholar Wickner S, Maurizi MR and Gottesman S (1999) Posttranslational quality control: folding, refolding, and degrading proteins. Science, 286, 1888–1893.CrossrefCASPubMedWeb of Science®Google Scholar Zaika A, Marchenko N and Moll UM (1999) Cytoplasmically ‘sequestered’ wild type p53 protein is resistant to Mdm2-mediated degradation. J Biol Chem, 274, 27474–27480.CrossrefCASPubMedWeb of Science®Google Scholar Zerrahn J, Deppert W, Weidemann D, Patschinsky T, Richards F and Milner J (1992) Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene, 7, 1371–1381.CASPubMedWeb of Science®Google Scholar Zhang W, Guo XY, Hu GY, Liu WB, Shay JW and Deisseroth AB (1994) A temperature-sensitive mutant of human p53. EMBO J, 13, 2535–2544.Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Zhao Z, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH and Levine AJ (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev, 14, 981–993.CrossrefCASPubMedWeb of Science®Google Scholar Zhen L and Cyr DM (1998) Protein folding activity of hsp70 is modified differentially by the hsp40 co-chaperones Sis1 and Ydj1. J Biol Chem, 273, 27824–27830.CrossrefPubMedWeb of Science®Google Scholar Zylicz M, LeBowitz JH, McMacken R and Georgopoulos C (1983) The dnaK protein of Escherichia coli possesses an ATPase and autophosphorylating activity and is essential in an in vitro DNA replication system. Proc Natl Acad Sci USA, 80, 6431–6435.CrossrefCASPubMedWeb of Science®Google Scholar Previous ArticleNext Article Read MoreAbout the coverClose modalView large imageVolume 20,Issue 17,September 3, 2001Cover. Pseudo-coloured scanning electron micrographs of a ciliated protozoan, Oxytricha sp. This organism has two types of nuclei, a germinal micronucleus and a somatic macronucleus; the latter is a bag of individual genes, which is an unusual genome organization in eukaryotes. The image shows two protozoa, the larger presumably eating the smaller one; cannibalism is not unusual in this species. Gopal Murti is the Director of Scientific Imaging at St Jude Children's Research Hospital, Memphis, TN, and an adjunct professor of pathology at the University of Tennessee, with research interests in virus--cell interactions and leukaemic cell--stromal cell interactions. He believes that this protozoan, upon which he collaborates with Dr David Prescott, provides an ideal model to study eukaryotic chromosome structure and function. Volume 20Issue 173 September 2001In this issue FiguresReferencesRelatedDetailsLoading ...